Browsing “September, 2019 | EVERSANA”

EVERSANA Sponsors the IntegriChain Access Insights Conference

Please join the EVERSANA team in Atlanta GA, as we discuss challenges that access teams face today and looking into the future on topics such as: Rationalizing gross-to-net Speeding time to therapy Improving patient adherence Optimizing product distribution, market access, and patient access On Tuesday, October 21 at 2:30 pm EST, Tom Doyle, SVP of […]

EVERSANA Sponsors the Rare Diseases and Orphan Products Breakthrough Summit

Improving the lives of people with rare diseases. The National Organization for Rare Disorders (NORD®), an independent nonprofit, is leading the fight to improve the lives of rare disease patients and families. NORD is committed to accelerating research, raising awareness, providing valuable information and driving public policy that benefits the millions of Americans impacted by […]

EVERSANA Sponsors Global Genes’ RARE Patient Advocacy Summit

As the largest gathering of rare disease patients, caregivers, thought leaders and other rare disease stakeholders in the world, the RARE Patient Advocacy Summit is an unparalleled opportunity to forge meaningful connections with other rare advocates and take home actionable strategies and tools to accelerate change. Summit Experience: • A jam-packed, two-day program filled with […]

Connect with EVERSANA at CBI’s Outcomes-Based Agreements & Innovative Payer Contracting

EVERSANA is attending the CBI’s Outcomes-Based Agreements & Innovative Payer Contracting in Philadelphia, PA from October 2-3. EVERSANA Managing Consultant, Robert Blank, will present his session “Value Based Contracts – Operational Challenges and Best Practices” on Wednesday, October 2 at 4:30 pm. Blank recently wrote a white paper titled, “Pharmaceutical Contracting from Volume to Value” […]

Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines

PALO ALTO, Calif. And CHICAGO – September 10, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by […]

EVERSANA is a Proud Sponsor of Cell & Gene Meeting on the Mesa

EVERSANA is a proud sponsor of Cell & Gene Meeting on the Mesa, one of the foremost conferences known for bringing together industry leaders to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to […]